THE founder of animal drug company Chemeq Ltd, Dr Graham Melrose, has retired as a non-executive director. Dr Melrose had been involved with Chemeq since it was founded in 1989.
BENTLEY biotech company, Chemeq Ltd, has settled its long-running dispute with the Australian Securities and Investments Commission with an agreement to pay a $500,000 fine.
ASIC proceedings against biotech company Chemeq Ltd have been resolved, with the Federal Court today approving the ASIC-suggested penalty of $500,000, payable by Chemeq, in relation to proceedings against the company.
Biotech company Chemeq Ltd announced today that it had achieved a gross revenue in excess of $4 million, and possessed over $28 million in cash reserves, satisfying the final milestone covenant in the convertible bond deed poll issued early last year.
Bentley-based veterinary medical technology company Chemeq Limited posted a half-year net loss of $13.6 million to December 31 2005, as it works its way through the commercialisation process for its technology.
VETERINARY pharmaceutical company Chemeq has announced that it has sustained a small contained fire at its manufacturing facility in Rockingham, which it says was extinguished in minutes.
LOCAL veterinary drug producer Chemeq has received notice from its investors Mizuho International, Stark Trading and Shepherd Investments, of their intention to secure their $40 million convertible bo
EMERGING local veterinary pharmaceutical company Chemeq has secured patent protection for its polymeric antimicrobial product in China until the year 2020.
US-based investment management group Stark Investments has joined with Japanese-owned Mizuho Financial Group to complete a $60 million capital raising for biotech company Chemeq.Stark was nominated as
PHARMACEUTICAL company Chemeq has deferred the planned expansion of its Rockingham drug factory after being forced to scale back its capital raising from $50 million to $30 million.The recently comple
Shares in pharmaceutical drug company Chemeq plunged in value this week as the market responded to adverse commercialisation and cash-flow reports.Investors discounted the company’s positive news, inc
Chemeq commercial trial succeedsAN independent commercial trial of Chemeq’s polymeric antimicrobial product for pigs has been completed at a New Zealand pig production farm with successful results.The
PHARMACEUTICAL company Chemeq has raised $10 million through a heavily discounted placement to clients of Bell Potter Securities.The placement was at $4.55 per share, well below the recent trading pri
